Wockhardt Ltd - Company Profile
Powered by 
All the data and insights you need on Wockhardt Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Wockhardt Ltd Strategy Report
- Understand Wockhardt Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Wockhardt Ltd (Wockhardt) is a pharmaceutical company that manufactures and markets vaccines, active pharmaceutical ingredients, formulations and biosimilars. Its product portfolio caters to various therapeutic areas including orthopedics, dental care, dermatology, rheumatology, gynecology, pediatrics, cardiology, pain management, nephrology, neurology and diabetes. The company also concentrates its research in new chemical entities (NCE), generics, abbreviated new drug applications (ANDAs), biosimilars, novel drug delivery systems (NDDS). It operates in India, the US, the UK and the emerging markets. Wockhardt is headquartered in Mumbai, Maharashtra, India.
Headquarters
India
Address
Wockhardt Towers, Bandra Kurla Complex, Bandra (East), Mumbai, Maharashtra, 400051
Website
www.wockhardt.com
Telephone
91 22 26534444
No of Employees
2,740
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
WOCKPHARMA (NSE)
Revenue (2022)
$337.8M
-17.9%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-129.1%
(2022 vs 2021)
Market Cap*
$1.0B
Net Profit Margin (2022)
XYZ
-179.3%
(2022 vs 2021)
* As of and is in US$
Wockhardt Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| - | - |
| Active Pharmaceutical Ingredients | Biovac-B |
| Vaccines | Wepox |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Business / Operations Closure | In February, the company shut down its manufacturing facility at Morton Grove, Illinois, the US. |
| 2022 | Contracts/Agreements | In March, the company entered into an agreement with Serum Life Sciences UK for manufacturing multiple vaccines and delivering a global vaccine programme. |
| 2021 | Contracts/Agreements | In August, the company and the Russian Direct Investment Fund (RDIF) entered into an agreement to to produce Sputnik V and Sputnik Light vaccines against COVID-19. |
Competitor Comparison
| Key Parameters | Wockhardt Ltd | Sandoz Inc | Alcon Inc | Sun Pharmaceutical Industries Ltd | Dr. Reddy's Laboratories Ltd |
|---|---|---|---|---|---|
| Headquarters | India | United States of America | Switzerland | India | India |
| City | Mumbai | Princeton | Fribourg | Mumbai | Hyderabad |
| State/Province | Maharashtra | New Jersey | Freiburg | Maharashtra | Telangana |
| No. of Employees | 2,740 | - | 25,315 | 41,000 | 24,832 |
| Entity Type | Public | Private | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Habil Khorakiwala | Chairman | Executive Board | - | - |
| Deepak Madnani | Chief Financial Officer | Senior Management | 2022 | - |
| Murtaza Khorakiwala | Managing Director; Director | Executive Board | 2009 | - |
| Huzaifa Khorakiwala | Director | Executive Board | 1996 | - |
| Ajay Sahni | President - Wockhardt France; Managing Director - Wockhardt Bio; Managing Director - Pinewood Healthcare | Senior Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward